
# Company
14.01.2025
ALBIS and Arkema partner in the distribution of high-performance medical grade polymers for the healthcare market
Hamburg, January 14, 2025 – Effective immediately, ALBIS will distribute Arkema's medical range of Pebax® MED thermoplastic elastomers, Rilsan® MED polyamide 11, Rilsamid® MED polyamide 12, Rilsan® Clear MED transparent polyamide, and Kynar® MED PVDF.
As one of the leading distributors of engineering and high-performance plastics, ALBIS is expanding its portfolio to include advanced polymers from Arkema, a global leader in Specialty Materials. Their territory includes Europe, North Africa, and the Middle East.
Arkema's high-performance medical grade materials meet stringent biocompatibility requirements and are compliant with USP Class VI and ISO 10993 regulations. They provide robust solutions specifically designed for critical applications in the healthcare sector – from minimally invasive medical devices to high-performance tubing and equipment. These polymers are known for their chemical resistance, flexibility and compliance with industry standards, supporting the strict requirements of manufacturers in the healthcare field.
“We are very pleased to add Arkema’s renowned brands to our healthcare portfolio,” said Mike Freudenstein, Senior Director Marketing Healthcare & Industry Management. “These high-performance medical-grade materials perfectly complement the existing offering of ALBIS: we can now provide greater value by offering an even more comprehensive portfolio of advanced polymers – including bio-based solutions – to our customers in the healthcare sector.”
David Dupont, Vice President of the Specialty Polyamides business at Arkema, shares this enthusiasm for the partnership: “With our collaboration with ALBIS, we are making our advanced materials even more accessible than before to meet growing demand and support innovation in the healthcare market. ALBIS is known for its outstanding technical know-how and service and we look forward to a successful collaboration.”

Are looking forward to the collaboration (from left): Daniel Stöcker (ALBIS), David Dupont (Arkema), Mike Freudenstein (ALBIS), Fidele Nizeyimana (Arkema)